Literature DB >> 17826236

Peripheral arterial disease affects ground reaction forces during walking.

Melissa M Scott-Pandorf1, Nicholas Stergiou, Jason M Johanning, Leon Robinson, Thomas G Lynch, Iraklis I Pipinos.   

Abstract

OBJECTIVE: Claudication is the most common manifestation of peripheral arterial disease (PAD), producing significant ambulatory compromise. The gait of claudicating patients has been evaluated using primarily temporal and spatial parameters. With the present study, we used advanced biomechanical measures to further delineate the ambulatory impairment of claudicating patients. We hypothesized that the claudicating legs of PAD patients have an altered kinetic gait pattern compared with normal legs from control subjects.
METHODS: Ambulation kinetics (ground reaction forces) were evaluated in claudicating patients and compared with age-matched healthy controls. Forces were analyzed in the vertical, anterior-posterior, and medial-lateral directions. Time from heel touch-down to toe-off (stance time) and time spent in double-limb support were also evaluated.
RESULTS: The study recruited 14 PAD patients (age, 58 +/- 3.4 years; weight, 80.99 +/- 15.64 kg) with femoropopliteal occlusive disease (ankle-brachial index [ABI], 0.56 +/- 0.03) and five controls (age, 53 +/- 3.4 years; weight, 87.38 +/- 12.75 kg; ABI, >or=1.00). Vertical force curve evaluation demonstrated significant flattening in claudicating patients resulting in a lower and less fluctuant center of mass when ambulating. In the anterior-posterior direction, claudicating patients demonstrated significantly decreased propulsion forces. In the medial-lateral direction, they had significantly increased forces consistent with wider steps and an inability to swing their legs straight through. Claudicating patients demonstrated a greater stance time and time in double limb support compared with healthy controls. Most importantly, gait abnormalities were present before the onset of claudication, with gait worsening after the onset of claudication.
CONCLUSION: Claudicating patients demonstrate significant gait impairments that are present even before they experience any limb discomfort. These alterations may make them feel more stable and secure while attempting to minimize use of the affected limb. Advanced biomechanical analysis, using ambulation kinetics, permits objective and quantitative evaluation of the gaits of claudicating patients. Such evaluation may point to new rehabilitation strategies and provide objective measurement of functional outcomes after medical and surgical therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17826236     DOI: 10.1016/j.jvs.2007.05.029

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  19 in total

1.  Abnormal joint powers before and after the onset of claudication symptoms.

Authors:  Panagiotis Koutakis; Jason M Johanning; Gleb R Haynatzki; Sara A Myers; Nicholas Stergiou; G Matthew Longo; Iraklis I Pipinos
Journal:  J Vasc Surg       Date:  2010-08       Impact factor: 4.268

2.  Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.

Authors:  Jennifer M Yentes; Jessie M Huisinga; Sara A Myers; Iraklis I Pipinos; Jason M Johanning; Nicholas Stergiou
Journal:  J Appl Biomech       Date:  2012-05       Impact factor: 1.833

3.  Supervised walking exercise therapy improves gait biomechanics in patients with peripheral artery disease.

Authors:  Molly N Schieber; Iraklis I Pipinos; Jason M Johanning; George P Casale; Mark A Williams; Holly K DeSpiegelaere; Benjamin Senderling; Sara A Myers
Journal:  J Vasc Surg       Date:  2019-08-20       Impact factor: 4.268

4.  Abnormal myofiber morphology and limb dysfunction in claudication.

Authors:  Panagiotis Koutakis; Sara A Myers; Kim Cluff; Duy M Ha; Gleb Haynatzki; Rodney D McComb; Koji Uchida; Dimitrios Miserlis; Evlampia Papoutsi; Jason M Johanning; George P Casale; Iraklis I Pipinos
Journal:  J Surg Res       Date:  2015-02-13       Impact factor: 2.192

5.  Gait deficiencies associated with peripheral artery disease are different than chronic obstructive pulmonary disease.

Authors:  John D McCamley; Eric J Pisciotta; Jennifer M Yentes; Shane R Wurdeman; Stephen I Rennard; Iraklis I Pipinos; Jason M Johanning; Sara A Myers
Journal:  Gait Posture       Date:  2017-06-27       Impact factor: 2.840

6.  Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication.

Authors:  Panagiotis Koutakis; Iraklis I Pipinos; Sara A Myers; Nicholas Stergiou; Thomas G Lynch; Jason M Johanning
Journal:  J Vasc Surg       Date:  2009-10-17       Impact factor: 4.268

7.  The effect of pharmacological treatment on gait biomechanics in peripheral arterial disease patients.

Authors:  Jessie M Huisinga; Iraklis I Pipinos; Jason M Johanning; Nicholas Stergiou
Journal:  J Neuroeng Rehabil       Date:  2010-06-07       Impact factor: 4.262

8.  Peripheral arterial disease affects the frequency response of ground reaction forces during walking.

Authors:  Denise McGrath; Timothy N Judkins; Iraklis I Pipinos; Jason M Johanning; Sara A Myers
Journal:  Clin Biomech (Bristol, Avon)       Date:  2012-09-09       Impact factor: 2.063

9.  Gait kinematics and kinetics are affected more by peripheral arterial disease than by age.

Authors:  Sara A Myers; Bryon C Applequist; Jessie M Huisinga; Iraklis I Pipinos; Jason M Johanning
Journal:  J Rehabil Res Dev       Date:  2016

10.  Increased minimum toe clearance variability in patients with peripheral arterial disease.

Authors:  Troy J Rand; Shane R Wurdeman; Jason M Johanning; Iraklis I Pipinos; Sara A Myers
Journal:  Med Eng Phys       Date:  2015-10-24       Impact factor: 2.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.